Belvedere Trading »

Vaneck Vectors Pharmaceutical etf shares owned by Belvedere Trading

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 34k 103.17
2021-09-30 $1.0M 14k 72.39
2020-12-31 $3.5M 53k 66.48

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Southern Company (SO)
Meta Platforms Cl A Call Option (META)
Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Advanced Micro Devices (AMD)
Spdr Gold Tr Gold SHS (GLD)
Amazon (AMZN)
Broadcom (AVGO)
Palantir Technologies Cl A (PLTR)
Strategy Inc Cl A New (MSTR)

View all positions for Belvedere Trading

Top funds holding Vaneck Vectors Pharmaceutical etf

Healthcare Of Ontario Pension Plan Trust Fund
Goldman Sachs Group
British Columbia Investment Management Corporation
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Bnp Paribas Arbitrage, Snc
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Adamsbrown Wealth Consultants
Susquehanna International
UBS Group
LPL Financial

View all funds holding Vaneck Vectors Pharmaceutical etf